JP2024516621A5 - - Google Patents
Info
- Publication number
- JP2024516621A5 JP2024516621A5 JP2023565183A JP2023565183A JP2024516621A5 JP 2024516621 A5 JP2024516621 A5 JP 2024516621A5 JP 2023565183 A JP2023565183 A JP 2023565183A JP 2023565183 A JP2023565183 A JP 2023565183A JP 2024516621 A5 JP2024516621 A5 JP 2024516621A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- group
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163177692P | 2021-04-21 | 2021-04-21 | |
| US63/177,692 | 2021-04-21 | ||
| PCT/US2022/025614 WO2022226102A1 (en) | 2021-04-21 | 2022-04-20 | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516621A JP2024516621A (ja) | 2024-04-16 |
| JP2024516621A5 true JP2024516621A5 (cg-RX-API-DMAC7.html) | 2025-04-08 |
Family
ID=83723402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565183A Pending JP2024516621A (ja) | 2021-04-21 | 2022-04-20 | イヌ細胞傷害性ｔリンパ球関連タンパク質４（ｃｔｌａ－４）に対するイヌモノクローナル抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12110331B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4326324A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024516621A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216131A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022226102A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3216131A1 (en) * | 2021-04-21 | 2022-10-27 | Nicola J. MASON | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) |
| US20240358834A1 (en) * | 2023-04-28 | 2024-10-31 | The Trustees Of The University Of Pennsylvania | Novel cd19-targeting polypeptides and cd19-directed immunotherapies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA314534A (en) * | 1931-08-25 | The United States Gypsum Company | Roof or floor | |
| US7261890B2 (en) * | 2001-12-21 | 2007-08-28 | Idexx Laboratories, Inc. | Methods for using canine immunoglobulin variable domains and caninized antibodies |
| US8722587B2 (en) * | 2008-04-09 | 2014-05-13 | The Trustees Of The University Of Pennsylvania | Single chain fragment variable antibody libraries and uses thereof |
| CA3145345A1 (en) * | 2019-07-15 | 2021-01-21 | Intervet International B.V. | Caninized antibodies against canine ctla-4 |
| CA3216131A1 (en) * | 2021-04-21 | 2022-10-27 | Nicola J. MASON | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) |
-
2022
- 2022-04-20 CA CA3216131A patent/CA3216131A1/en active Pending
- 2022-04-20 EP EP22792435.4A patent/EP4326324A4/en active Pending
- 2022-04-20 WO PCT/US2022/025614 patent/WO2022226102A1/en not_active Ceased
- 2022-04-20 JP JP2023565183A patent/JP2024516621A/ja active Pending
-
2023
- 2023-10-20 US US18/491,182 patent/US12110331B2/en active Active
-
2024
- 2024-09-04 US US18/823,863 patent/US20250171541A1/en active Pending